1
TITLE: Ethambutol and meropenem/clavulanate synergy promotes enhanced extracellular and intracellular killing of Mycobacterium tuberculosis
AUTHORS: Olivenca, Francisco; Pires, David; Silveiro, Catia; Gama, Bianca; Holtreman, Frederico; Anes, Elsa; Catalao, Maria Joao;
PUBLISHED: 2024, SOURCE: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, VOLUME: 68, ISSUE: 4
INDEXED IN: WOS CrossRef: 1
IN MY: ORCID
2
TITLE: Unravelling the triad of neuroinvasion, neurodissemination, and neuroinflammation of human immunodeficiency virus type 1 in the central nervous system  Full Text
AUTHORS: Calado, Marta; Ferreira, Rita; Pires, David; Santos Costa, Quirina; Anes, Elsa; Brites, Dora; Azevedo Pereira, Jose Miguel;
PUBLISHED: 2024, SOURCE: REVIEWS IN MEDICAL VIROLOGY, VOLUME: 34, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 1
IN MY: ORCID
3
TITLE: Ethambutol and meropenem/clavulanate synergy promotes enhanced extracellular and intracellular killing of Mycobacterium tuberculosis
AUTHORS: Francisco Olivença; David Pires; Cátia Silveiro; Bianca Gama; Frederico Holtreman; Elsa Anes; Maria João Catalão;
PUBLISHED: 2024, SOURCE: Antimicrobial Agents and Chemotherapy, VOLUME: 68, ISSUE: 4
INDEXED IN: Scopus CrossRef
IN MY: ORCID
4
TITLE: Synthesis, Activity, Toxicity, and In Silico Studies of New Antimycobacterial N-Alkyl Nitrobenzamides  Full Text
AUTHORS: Pais, Joao P.; Antoniuk, Olha; Pires, David; Delgado, Tiago; Fortuna, Andreia; Costa, Paulo J.; Anes, Elsa; Constantino, Luis;
PUBLISHED: 2024, SOURCE: PHARMACEUTICALS, VOLUME: 17, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
5
TITLE: Development of New Drugs to Treat Tuberculosis Based on the Dinitrobenzamide Scaffold  Full Text
AUTHORS: Delgado, Tiago; Pais, Joao P.; Pires, David; Estrada, Filipe G. A.; Guedes, Rita C.; Anes, Elsa; Constantino, Luis;
PUBLISHED: 2024, SOURCE: PHARMACEUTICALS, VOLUME: 17, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
7
TITLE: Synthesis, Activity, Toxicity, and In Silico Studies of New Antimycobacterial N-alkyl Nitrobenzamides as Potential DprE1 Inhibitors
AUTHORS: João Pedro Pais; Olha Antoniuk; David Pires; Tiago Delgado; Andreia Fortuna; Paulo J Costa; Elsa Anes; Luis Constantino;
PUBLISHED: 2024
INDEXED IN: CrossRef
IN MY: ORCID
8
TITLE: Development of New Drugs to Treat Tuberculosis Based on the Dinitrobenzamide Scaffold  Full Text
AUTHORS: Tiago Delgado; João P Pais; David Pires; Filipe G A Estrada; Rita C Guedes; Elsa Anes; Luis Constantino;
PUBLISHED: 2024, SOURCE: Pharmaceuticals, VOLUME: 17, ISSUE: 5
INDEXED IN: CrossRef
IN MY: ORCID
9
TITLE: Role of Type I Interferons during Mycobacterium tuberculosis and HIV Infections  Full Text
AUTHORS: Anes, Elsa; Azevedo Pereira, Jose Miguel; Pires, David;
PUBLISHED: 2024, SOURCE: BIOMOLECULES, VOLUME: 14, ISSUE: 7
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
10
TITLE: Cystatin F Depletion in Mycobacterium tuberculosis-Infected Macrophages Improves Cathepsin C/Granzyme B-Driven Cytotoxic Effects on HIV-Infected Cells during Coinfection  Full Text
AUTHORS: Manoj Mandal; David Pires; Marta Calado; José Miguel Azevedo-Pereira; Elsa Anes;
PUBLISHED: 2024, SOURCE: International Journal of Molecular Sciences, VOLUME: 25, ISSUE: 15
INDEXED IN: CrossRef
IN MY: ORCID
Page 1 of 6. Total results: 58.